Literature DB >> 18979167

Why and when PCI, why and when thrombolysis?: thrombolysis.

Giovanni Melandri1, Franco Semprini, Samuele Nanni, Daniela Calabrese, Fabio Vagnarelli, Angelo Branzi.   

Abstract

Mesh：

Year:  2008        PMID： 18979167     DOI： 10.1007/s11739-008-0200-9

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  18 in total

1.  Primary angioplasty or thrombolysis for acute myocardial infarction?

Authors:  Giovanni Melandri
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

2.  Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction network.

Authors:  Antonio Manari; Paolo Ortolani; Paolo Guastaroba; Gianni Casella; Luigi Vignali; Elisabetta Varani; Giancarlo Piovaccari; Vincenzo Guiducci; Gianfranco Percoco; Stefano Tondi; Francesco Passerini; Andrea Santarelli; Antonio Marzocchi
Journal:  Eur Heart J       Date:  2008-07-10       Impact factor: 29.983

3.  Letter by Melandri regarding article, "A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction".

Authors:  Giovanni Melandri
Journal:  Circulation       Date:  2008-05-06       Impact factor: 29.690

4.  Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

Authors:  Z M Chen; L X Jiang; Y P Chen; J X Xie; H C Pan; R Peto; R Collins; L S Liu
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

5.  Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy.

Authors:  D J Magid; B N Calonge; J S Rumsfeld; J G Canto; P D Frederick; N R Every; H V Barron
Journal:  JAMA       Date:  2000-12-27       Impact factor: 56.272

6.  Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction.

Authors:  James G Jollis; Mayme L Roettig; Akinyele O Aluko; Kevin J Anstrom; Robert J Applegate; Joseph D Babb; Peter B Berger; David J Bohle; Sidney M Fletcher; J Lee Garvey; William R Hathaway; James W Hoekstra; Robert V Kelly; William T Maddox; Joseph R Shiber; F Scott Valeri; Bradley A Watling; B Hadley Wilson; Christopher B Granger
Journal:  JAMA       Date:  2007-11-04       Impact factor: 56.272

7.  Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.

Authors:  Francisco Fernandez-Avilés; Joaquín J Alonso; Alfonso Castro-Beiras; Nicolás Vázquez; Jesús Blanco; Juan Alonso-Briales; Juan López-Mesa; Felipe Fernández-Vazquez; Isabel Calvo; Luis Martínez-Elbal; José A San Román; Benigo Ramos
Journal:  Lancet       Date:  2004 Sep 18-24       Impact factor: 79.321

8.  Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction.

Authors:  Dennis T Ko; Yongfei Wang; David A Alter; Jeptha P Curtis; Saif S Rathore; Therese A Stukel; Fredrick A Masoudi; Joseph S Ross; JoAnne M Foody; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2008-02-19       Impact factor: 24.094

9.  Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines program.

Authors:  Rajendra H Mehta; Vincent J Bufalino; Wenqin Pan; Adrian F Hernandez; Christopher P Cannon; Gregg C Fonarow; Eric D Peterson
Journal:  Am Heart J       Date:  2008-03-05       Impact factor: 4.749

10.  Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries.

Authors:  Brahmajee K Nallamothu; Mary A M Rogers; Michael E Chernew; Harlan M Krumholz; Kim A Eagle; John D Birkmeyer
Journal:  JAMA       Date:  2007-03-07       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.